BML Pharmaceuticals Overview

  • Founded
  • 1996
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 2

BML Pharmaceuticals General Information

Description

Developer of proprietary prescriptive pharmaceutical products in the areas of cancer treatment. The company's products are formulated into therapeutics which range from the prevention and treatment of dermal disease to mucositis for cancer patients.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 1129 Northern Boulevard
  • Suite 406
  • Manhasset, NY 11030
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BML Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BML Pharmaceuticals‘s full profile, request access.

Request a free trial

BML Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Barry Libin Chairman & Chief Executive Officer
To view BML Pharmaceuticals’s complete executive team members history, request access »

BML Pharmaceuticals Board Members (1)

Name Representing Role Since
00000 00000 Self Chairman & Chief Executive Officer 000 0000
To view BML Pharmaceuticals’s complete board members history, request access »

BML Pharmaceuticals Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BML Pharmaceuticals‘s full profile, request access.

Request a free trial